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Introdu ction 
Cell specific drug dch\ery is a major challenge in c hemotherapeutic stmlegies 1argcting. 
panicularl) in cancer s1ra1egics. Side effeclS for non•spccifi c up1ake of chemolherapcutic 
drugs by normal healthy cells include hair loss, vomiting. nausea. and other negative 
symptoms. The use ofnanoparttcles such as those deri\ed from protein c:igc structures 
pn:scnl potcnlially useful agcn1s for drug deliH~ry by encapsulatio n of drugs o n the 
interior of the protein cage nanoparticle. Howevi:r. while strategics for encapsulation of 
drugs arc plentiful, methods for prog.rnmmmg site/cell specific deli,·ery ofnonoparticles 
arc needed. One polen1ial protein cage platform for drug delivery is the virus•likc particle 
(VLP) derived from 1he bacteriopha£C Hong Kong 9 7 (HK9 7). The HK97 VLP self 
assembles from 420 copies o f the GP5 coat pro1ein to form 3 hollow icosahedral 56nm 
struc ture. HK97 is an inlercs ting pro1cin because it h35 been obscned 10 require cell 
1arge1ing mo ie ties to be added 10 the exte.rior for entry in10 cells. A)~· 
The research prescn1cd here looks 10 examine a proof of concept _ 
s trategy for loca ll;,mg HK97 VLPs based on chemo-sensitivc 
progmmming o f the exterior. The approach looks at exploiting · 
the property of cancer cells to upreg ufale metaJlopro1eases in the 
cancer m1croem ironmcnt. We hypothesize that peptides can be B) -
added lo the oulside of the HK9 7 VLP that program the 
local1Lat1on and dcpos ilion of HK9 7 VLPs 103ded \,; th drugs 
\\.hen pro1eases arc present To e, aluare this hypothesis we 
exam me the genetic attachment of a model peptide containing 
poly•phcnylalamnc nankcd by an a.spartic acid and a ~ 
solub1ll.1mg poly•lysmc pcpltde sequence 10 I.he G PS protein C - figarr I. The baclerioph•1e 
rcm1inus. Trealmenl w11h N-aspanate prote.a.sc. a ··moder· HK97. A) TEM image of the 
protease. 1s expected lo lead 10 VLP self•as.semblv and HK97 b3.ctcriophagc. B) HK97 
aggrcga11on m suppon of our proposed hypolhes1~. ~;~:~;!;:"1;~s!":c~u
1
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P roperties of t he HK97 VLP Ideal for Drug Deliverv 
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F'igure 2. Internal and ettl"rna l structural charaC"teristic:1 of 
111<97 VLP. Inner surface of the IIK97 has e,poscd amino acid 
.. -s1duc~ (magenta and orange). E,1cnor surface has 1he C-
cmunu~ of GPS ired) e..:po,ed. 
Large ho llow inlcrior for drug 
loading. 
Drugs can diffusion through 2 
nm sized pores in the cage. 
Exposed C-tcrminus as an 
attachment s ite on exterio r 
(Figu re 2). 
Highly stable for delivery in 
vivo. 
Ideal nanoparticle size for 
accumulation in cancero us 
lissuc (EPR effect ). 
~l anipu lati ng HK97 VLP For Encapsu la tion and Self Assembly 
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::-;;: .. ,.. , ;nn ~r rareelt"d drug deli,·try slra1"1t)'. 
Engineer the interior 
surface for a llowing 
locali7..ation o f 
therapeutics. 
Engineer exlcrior surface 
for auachmcnl of cell 
1arge1ing moieties. 
Combining inlemal drug 
packaging wi1h external 
modification for cell 
targc1ing will produce 
··smart bomb .. drug 
delivery nanopartic les. 
Targeting Metalloproteases 
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Figure 4. Scht"matic or 
l\lelalloproteHe A<"th·lty 
" "ith VLP In CancH 
l\tlcroen,i ronmenl 
, ..t:,t~l~r~e~~ 
• Cancer microcnvironmcnts arc known to contain proteases. which arc proteins thal 
cut/digest other pro te ins at specific amino acids. 
• The VLP exterior can be programmed wilh peptides thal arc modified/removed by 
mctalloproleases that arc in the microcnvironmcnt of the cancer. but arc no1 found 
e lsewhere. 
• Designing the peptides to cause self.assembly upon digcs1ion/cut1ing by the protease is 
expected to localize the drug delivery VLP 
Exploiting Self Assembling Peptides ~ : 
Protease N-Aspartate I 
.. ~-- ( ~ 
• The de novo 
design of peptides 
that self-assemble 
through non-
covalenl 
interactions into 
higher order 
s1ruc1ures is well 
studied. 
Protease Cul  
Site Peptide Self-Assembly 
Figure 5. RepreHntatio n o f Process of Cutting and AsHmbling the 
HK97 Peptide by Pl-Stacking 
• Peptides comprised of 2 or 3 consecutive pheny la lanine amino acids (f) arc known to 
spontaneously form large nanoslructures (tubes or spheres) through Pi-stacking 
interaelions bc1wccn F residues. 
• Design ofa pcplide containing F residues that prevents Pi-stacking until modified by a 
protease is a potential strategy for chemically programming cell targeting by exploiting 
lhe self-assembly properties of the poly•F peptide 
• Amino acids that repel and maintain solubili1y. such as lysine (K). are expected 10 
prcvcnl assembly o f poly-F peptides 
Incorpora ting S ite for Targeting Moieties 
.... """' 
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Figure 6. Pla:i;mid conlaining I-IK97 C P5 
gene dHlgnrd for modular 
incorporation or peptldt" gt"nu. Dc:!iign 
features include a modular poly.glycine 
spacer (black) between the GP5 coat 
protein (blue) and pcplidc in.sen (green) 
that allows spatial flexibility and separation 
upon gene expression. 
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C-lenninus exposed to exterior permits geneuc 
addition of peptides to the exterior of the 
HK9 7 VLP. 
Plasmid was cons tructed enabling pe-ptide 
sequences to be added in a modular fashion 
using Kpnl and Xhol restriction enzymes 
(Figu re 6). 
Peptides appended could be used direclly for 
ce ll targeting or as molecular handles to attach 
targeting moieties. 
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Fli:arr 7. ~I Rcualrs rrem C•-•> PC1l or c .-... i- , _. •nrf ,,;;,u,ad•rd a_.ddrr 
DNA was e,tnctcd from F Coll oolon1a 
The DNA undef"'cnt Po l~-mCfll.c C tu..in Racuon j PCR I and 1hcn " ~ nm tm 0 
gel 
The gel 1s , 1.suahzcd m Fl2vrT 7 and mdudd .a ,ondard protein lmJJc.r d 
Based on the G P5 cool pc-otcm. colon1a th;aJ had lhc acne m1'Cncd 1n 1hc pla.!lm• 
wo uld h:n e hits at appm"m::atcl) 1100 buc piun 
The colonies" 1th the boldest bands ;at appn" 1rrustcly I 2fH') BP indu;utcd by ihc 
red arro" "en: scl«tcd for further totmg 
Sequencing of Gene lnsert.s 
s, auenc• Colony 1 
!o - ATGTCTGAACTCOCTCTCATTCAA,,U,A 
~ 
5·-ATGTCTGA.ACTCGCTCTCATT~ 
Translated to P r o tein 
'/ 
SegytQCt Colony 1 ~~ ~""IJ"Ol'.IU'JO'-U: 
~ WIIC.AU0K -<JGillOGGT..-nt)IOr.JICKY-U 
n«•n- 8. ~H•d•& ••d PrMn. T.-. ...... , .... M.n•Jb ., c.ao .. , On~ u,A 
DNA was rxtract.cd from the E c-oh lh;s.t n:a:t\.·cd ··tut,- b)· PC:R fo-r the m~d gene 
Scqucnc-mg ~-as pc--rfonocd by Eurofins Operon 5C'CJUCT)Clng ~ice 
A 11 hits 1ho"' ed correct sc-qucnc-c- opc"C'led (or all.lehmcnl the- f- Fl-0 KKK K gene: at the (.... 
tCTmmus ofGPS gc:-nic 
S umman' and Future Direction.s 
Gcnc n)C:()(fmg FFFDKK.KK has been succn.sfulJ) tncorporatc-d tnto the ~prc-nron 
\."CCtor for GPS 
Tnah arc undttv.<1) to t\aJU3J.e I.be c-xpn:·»aoo oflbc modified f fK97 VLP ( ,cne 
encoding FFFDKKKKJ<._ 
~1odified HK97 VLPs wdl be charx-tenzcd to dctcnnmc thctr .11.b-ih ty to 1-elf-
asse-mble aftCT :0..:· Aspart.ate- Protease tTe:aimcnt 
Designs ofpe:p(ides UW wdl alJov, ta.rgd.Ulg ofmctallopro~ in cancer CCII 
micnxm 1ronments are bctog e.x.ammcd m the case that our proof of conecpt 
are- succc:ssfut 'll1Jd1C1( 
Acknowledgements 
. ss ackno \,ledgcs suppon from L"T Honan Program 
.opp ackno" ledges support from the L'nl\er5i~ ofTc:u.s at TylCT . 
